Jan Willem de Cler

Jan Willem de Cler

President chez Fci Ophthalmics, Inc.

59 ans
Health Technology
Consumer Services
Distribution Services

Profil

Jan Willem de Cler is currently the Chairman at Implandata Ophthalmic Products GmbH.
He is also a Director at HYALTECH Ltd., Fci Sud Ltd., Fci Ophthalmics, Inc., and Fci SAS.
Previously, he was the Chief Executive Officer at Aaren Scientific, Inc. and the Managing Director at France Chirurgie Instrumentation SAS.
He also served as the Head-Surgical Ophthalmology at Carl Zeiss Meditec AG from 2010 to 2018 and as the Head-Sales & Marketing at Global Healthcare Exchange Europe GmbH.
Mr. de Cler holds an undergraduate degree from Nyenrode Business Universiteit and an MBA from the University of Oregon.

Postes actifs de Jan Willem de Cler

SociétésPosteDébut
Director/Board Member -
Fci Ophthalmics, Inc. President -
Fci Sud Ltd. Director/Board Member -
President -
Chairman 24/10/2023
Tous les postes actifs de Jan Willem de Cler

Anciens postes connus de Jan Willem de Cler

SociétésPosteFin
CARL ZEISS MEDITEC AG Human Resources Officer 30/09/2022
France Chirurgie Instrumentation SAS Chief Executive Officer -
Global Healthcare Exchange Europe GmbH Sales & Marketing -
Chief Executive Officer -
Voir l'expérience en détail de Jan Willem de Cler

Formation de Jan Willem de Cler

Nyenrode Business Universiteit Undergraduate Degree
University of Oregon Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jan Willem de Cler

Relations

39

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CARL ZEISS MEDITEC AG

Health Technology

Entreprise privées8
France Chirurgie Instrumentation SAS

Distribution Services

Global Healthcare Exchange Europe GmbH

Distribution Services

Health Technology

Health Technology

Electronic Technology

Fci Ophthalmics, Inc.

Fci Sud Ltd.

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jan Willem de Cler